Last Gasp for Qnexa?

September 21st, 2010 by MorganDowney Leave a reply »

September 21, 2010   

Vivus Pharmaceuticals announced today the results of the two-year study of their drug for obesity, Qnexa. The findings show, after two years, an 11% or 26 pound weight loss with low side effects. Question now is whether this is enough for the FDA to approve the drug contrary to a negative vote of their Advisory Committee in July.  79% of patients loss more than 5% of their body weight compared to 30% on placebo. 32% lost more than 15% compared to 7 % on placebo.

FDA should make its decision at the end of October.

Leave a Reply